Mdm2 and p53 are highly conserved from placozoans to man

被引:64
作者
Lane, David P. [1 ]
Cheok, Chit Fang [1 ]
Brown, Christopher [1 ]
Madhumalar, Arumugam [2 ]
Ghadessy, Farid J. [1 ]
Verma, Chandra [2 ]
机构
[1] ASTAR, Lab P53, Biomed Grove 8A, Singapore, Singapore
[2] ASTAR, Bioinformat Inst, Singapore, Singapore
关键词
p53; Mdm2; Trichoplax; Placozoan; DNA damage; tumor suppression; ZINC-FINGER DOMAIN; TUMOR-SUPPRESSOR; PHOSPHORYLATION; TRANSACTIVATION; ACETYLATION; ACTIVATION; MUTATIONS;
D O I
10.4161/cc.9.3.10516
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The p53 protein is the most commonly mutated tumor suppressor gene in man. Understanding of its evolutionary origins have been enhanced by the recent discovery of p53 family genes in the Sea Anemone Nematostella vectensis. This amino acid sequence conservation has been reflected in biological activity since the early p53 proteins, like their human counterparts, are responsible for DNA damage-induced cellular apoptosis, albeit restricted to the germ cell compartment in model organisms such as the nematode and fruit fly. In vertebrates from zebrafish to man the function of p53 is tightly and absolutely constrained by a negative regulator Mdm2. However the Mdm2 gene has not been detected in the genome of the model nematode (C. elegans) and insect (D. melanogaster) species. We have found that the p53 gene and the Mdm2 gene are present in Placozoans, one of the simplest of all free living multi-cellular organisms, implying that both proteins arose much earlier in evolution than previously thought. Detailed sequence analysis shows the exceptional retention of key features of both proteins from man to Placazoan implying that the p53-Mdm2 interaction and its regulation have been conserved from a basal eumetazoan since the pre-cambrian era over 1 billion years ago.
引用
收藏
页码:540 / 547
页数:8
相关论文
共 31 条
[1]  
Arumugam M, 2009, CELL CYCLE, V8, P2828
[2]   One billion years of p53/p63/p73 evolution [J].
Belyi, Vladimir A. ;
Levine, Arnold J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (42) :17609-17610
[3]  
Case DA., 2008, AMBER 10 University of California
[4]  
DeLano D. W., 2002, PYMOL MOL GRAPHICS S
[5]   Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 [J].
Dumaz, N ;
Meek, DW .
EMBO JOURNAL, 1999, 18 (24) :7002-7010
[6]   ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM [J].
GANNON, JV ;
GREAVES, R ;
IGGO, R ;
LANE, DP .
EMBO JOURNAL, 1990, 9 (05) :1595-1602
[7]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886
[8]   CRYSTAL-STRUCTURE OF THE TETRAMERIZATION DOMAIN OF THE P53 TUMOR-SUPPRESSOR AT 1.7 ANGSTROMS [J].
JEFFREY, PD ;
GORINA, S ;
PAVLETICH, NP .
SCIENCE, 1995, 267 (5203) :1498-1502
[9]   Structure-function-rescue: the diverse nature of common p53 cancer mutants [J].
Joerger, A. C. ;
Fersht, A. R. .
ONCOGENE, 2007, 26 (15) :2226-2242
[10]   Structural basis of DNA recognition by p53 tetramers [J].
Kitayner, Malka ;
Rozenberg, Haim ;
Kessler, Naama ;
Rabinovich, Dov ;
Shaulov, Lih ;
Haran, Tali E. ;
Shakked, Zippora .
MOLECULAR CELL, 2006, 22 (06) :741-753